Hedelin H, Holmäng S, Wiman L
Urologdivisionen, Området för kirurgi, Sahlgrenska sjukhuset, Göteborg.
Nord Med. 1997 Feb;112(2):48-51.
Transurethral resection of bladder tumours and recurrences accounts for a substantial part of the workload at a urology unit. With the aim of reducing costs, since 1992 we have performed transurethral resection as an out-patient procedure if possible. Transurethral resection as day surgery in selected patients has been enabled by the use of extirpation and fulguration under cover of intravesical lignocaine (lidocaine) anaesthesia or submucosal lignocaine injection. Before the introduction of the out-patient treatment policy, around 270 transurethral resections of bladder tumours were performed annually at a cost of SEK 5.7 million. During 1994 and 1995, almost half of the procedures could be performed in an out-patient setting, with minimal complications and a very high level of patient acceptance, the respective reductions in costs being SEK 2.4 million and SEK 3.2 million.
经尿道膀胱肿瘤切除术及其复发手术占泌尿外科工作量的很大一部分。为了降低成本，自1992年以来，我们尽可能将经尿道切除术作为门诊手术进行。通过在膀胱内利多卡因（利多卡因）麻醉或黏膜下利多卡因注射的掩护下进行切除和电灼，使得在选定患者中进行日间经尿道切除术成为可能。在引入门诊治疗政策之前，每年大约进行270例经尿道膀胱肿瘤切除术，费用为570万瑞典克朗。在1994年和1995年期间，几乎一半的手术可以在门诊进行，并发症极少，患者接受度非常高，成本分别降低了240万瑞典克朗和320万瑞典克朗。
